First Subject Recruited for Early-Phase Clinical Trial

About this update from Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd has released a press release. View Attachment

View stock analysis, news, and events for Neuroscientific Biopharmaceuticals Ltd.